Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone, and welcome to Pelthos Therapeutics 2025 fourth quarter and fiscal year financial results conference call. Pelthos issued a press release today announcing its financial results for the year ended December 31st, 2025. Copy can be found in the investor relations tab on the corporate website at www.pelthos.com. Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans, and prospects are forward-looking statements. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our current expectations expressed or implied by the forward-looking statements. Any such forward-looking statements represent management's estimates as of the date of this conference call. While the company may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, even if subsequent events cause its views to change. As a reminder, this conference call is being recorded and will remain available for 90 days. I'd now like to turn the floor over to Scott Plescia, Chief Executive Officer. Sir, you may begin. Thank you, Mike. Good morning, and welcome, everyone, to today's call. We're delighted to be with you today and to share with you our fourth quarter in annual operating results and highlights. Joining me today are Frank Nuttall, our CFO, and Cy Rangero, our Chief Commercial Officer. The fourth quarter of 2025 was an exciting and busy one for Peltos with great progress made in three key areas that I'll share a...